Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring Patient and Healthcare Professional Views and Experiences of the Current and Recommended Monitoring Strategies for Inflammatory Conditions Treated With Commonly Used Immune Suppressing Drugs

NCT05458531 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT05458531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05458531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring Patient and Healthcare Professional Views and Experiences of the Current and Recommended Monitoring Strategies for Inflammatory Conditions Treated With Commonly Used Immune Suppressing Drugs
Lead sponsor
University of Nottingham
Phase
Observational
Overall status
Completed
Start date
June 28, 2022
Completion date
February 8, 2023
Enrollment
664 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, inflammatory arthritis, inflammatory disease, psoriasis, psoriatic arthritis, reactive arthritis, rheumatoid arthritis, system; lupus erythematosus, ulcerative colitis